Practice
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Nextracker spinoff from Flex
We advised Nextracker on its spinoff
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
TruArc Partners acquisition of Meyer Laboratory and $179 million financing
We advised TruArc Partners on the acquisition and related financing arrangements
SEB $1.75 billion notes offering
The investment-grade notes are due 2027 and 2029
Lightyear Capital strategic investment in Prime Pensions
We advised Lightyear Capital on the transaction and related debt financing
REV Group $289.9 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering
Delinea acquisition of Fastpath Solutions
We are advising Delinea on the acquisition
Truist $15.5 billion sale of remaining stake in Truist Insurance to investor group
We are advising Truist on the transaction
HireRight $1.65 billion acquisition by General Atlantic and Stone Point Capital
We are advising the special committee of HireRight on the transaction
Cigna $4.5 billion senior notes offering
The senior notes are due 2029, 2031, 2034 and 2054
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition